Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion type Assertion NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_head.
- NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion description "[De novo or augmented inhaled glucocorticoid therapy was associated with significant reductions in the percentages of CD4 T cells expressing IL-5 and IL-4 mRNA, as well as improvements in lung function, symptom scores, and bronchial hyperresponsiveness to metacholine (PD20) in both the atopic and nonatopic asthmatics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_provenance.
- NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion evidence source_evidence_literature NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_provenance.
- NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion SIO_000772 11826234 NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_provenance.
- NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion wasDerivedFrom befree-20150227 NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_provenance.
- NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_assertion wasGeneratedBy ECO_0000203 NP495366.RAuJ5yJ8asuMXx2aoRGY0ArvX-JoV1X2f9b3azVL0ZkMo130_provenance.